Showing results (301-310 of 491) with videos related to
Sort By:
Pageof 50
Journal of Mass Spectrometry : JMS|June 2, 2004
Determining sequences and post-translational modifications of novel conotoxins in Conus victoriae using cDNA sequencing and mass spectrometryJennifer A Jakubowski, David A Keays, Wayne P Kelley, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1992
Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosisC V Jackson, V G Crowe, J D Frank, et al.Journal of the American College of Cardiology|December 6, 2008
Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivoDavid Erlinge, Christoph Varenhorst, Oscar O Braun, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2014
Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027Mini Kamboj, Kun Xiao, Anna Kaltsas, et al.Thrombosis and Haemostasis|June 27, 2002
An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregatesStanley J Marciniak, Mary A Mascelli, Mark I Furman, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
Phase I trial of intravenous and intraperitoneal administration of granulocyte-macrophage colony-stimulating factorG C Toner, J L Gabrilove, M Gordon, et al.Thrombosis and Haemostasis|October 9, 2008
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery diseaseOscar O Braun, Matilda Johnell, Christoph Varenhorst, et al.Platelets|June 24, 2008
Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjectsChristopher D Payne, Ying G Li, John T Brandt, et al.Thrombosis and Haemostasis|February 19, 2008
The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationJoseph A Jakubowski, Christopher D Payne, Ying G Li, et al.Peptides|December 5, 2006
Recombinant production and structural studies of the Aplysia water-borne protein pheromone enticin indicates it has a novel disulfide stabilized foldScott F Cummins, Fang Xie, Milind Misra, et al.Pageof 50